Semergen · 2026
[Effectiveness of digital therapy added to the usual intervention for smoking cessation in primary care].
СтатьяРандомизированное исследованиеАннотация на английскомНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Panisello Royo J M, Cuervo Arribas J, Tárraga Marcos P J, Rosich Domenech N, Lopez-Gil J F, Lleixa Rillo X, Godoy Mayoral R, Tárraga Lopez P J, en nombre y representación del Grupo Tecnología Digital y Tabaquismo
Аннотация
OBJECTIVE: To evaluate the effectiveness of adding a digital therapeutic intervention to usual care for smoking cessation in patients attended in primary care.
METHODS: A randomized controlled trial including 220 smokers allocated to two groups: usual care (G1; n=110) and usual care plus digital therapy (G2; n=110). Usual care followed the SEMERGEN REVERSE protocol. Sociodemographic and clinical variables, smoking history, nicotine dependence (Fagerström test), motivation to quit (Richmond test), and comorbidities were collected. Primary outcomes were smoking abstinence at 3 and 6months; secondary outcomes included percentage reduction in cigarette consumption.
RESULTS: Abstinence at 3months was higher in the digital therapy group than in the usual care group (59.1% vs. 44.5%; P=0.043). At 6months, abstinence rates were 50.0% in G2 and 35.5% in G1 (P=0.041). The percentage reduction in cigarette consumption was significantly greater in the digital therapy group (46.5±12.7%) compared with controls (25.4±12.0%) (P<0.001).
CONCLUSIONS: In a real-world primary care setting, adding a digital therapeutic intervention to usual care was associated with higher smoking abstinence rates and greater consumption reduction in the short and medium term.
METHODS: A randomized controlled trial including 220 smokers allocated to two groups: usual care (G1; n=110) and usual care plus digital therapy (G2; n=110). Usual care followed the SEMERGEN REVERSE protocol. Sociodemographic and clinical variables, smoking history, nicotine dependence (Fagerström test), motivation to quit (Richmond test), and comorbidities were collected. Primary outcomes were smoking abstinence at 3 and 6months; secondary outcomes included percentage reduction in cigarette consumption.
RESULTS: Abstinence at 3months was higher in the digital therapy group than in the usual care group (59.1% vs. 44.5%; P=0.043). At 6months, abstinence rates were 50.0% in G2 and 35.5% in G1 (P=0.041). The percentage reduction in cigarette consumption was significantly greater in the digital therapy group (46.5±12.7%) compared with controls (25.4±12.0%) (P<0.001).
CONCLUSIONS: In a real-world primary care setting, adding a digital therapeutic intervention to usual care was associated with higher smoking abstinence rates and greater consumption reduction in the short and medium term.